Banyan Biomarkers, Inc. — Form D/A

Banyan Biomarkers, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2016-09-27. The offering totals $10.0M, of which $3.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Norman FlaggDirectorSan Diego, CA
Jackson StreeterDirectorMiddletown, PA
Jackson StreeterExecutive OfficerMiddletown, PA
William Roper, Jr.DirectorArlington, VA
ANDREW PARKERDirectorRedondo Beach, CA
Steven RichieriDirectorSAN DIEGO, CA
Steven RichieriExecutive OfficerSAN DIEGO, CA
Herbert BoyerDirectorSan Diego, CA
Stanford WarshawskyDirectorSan Diego, CA
Nancy Denslow, PhDDirectorSan Diego, CA
Henry NordhoffDirectorSan Diego, CA
Henry NordhoffExecutive OfficerSan Diego, CA
Ronald Hayes, PhDDirectorSan Diego, CA
Ronald Hayes, PhDExecutive OfficerSan Diego, CA
Andrew von Eschenbach, MDDirectorSan Diego, CA
Julie PashkowskyExecutive OfficerSan Diego, CA
Tony GroverExecutive OfficerSan Diego, CA
Michael Catania, PhDExecutive OfficerSan Diego, CA
Ronald Hayes, Ph.D.DirectorSan Diego, CA
Ronald Hayes, Ph.D.Executive OfficerSan Diego, CA
Ronald Hayes, Ph.D.PromoterSan Diego, CA
Frederic SweeneyDirectorSan Diego, CA
Jackson Streeter, M.D.DirectorSan Diego, CA
Jackson Streeter, M.D.Executive OfficerSan Diego, CA
Nancy Denslow, Ph.D.DirectorSan Diego, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-06-18D$3.0M$2.3M
2019-01-04D$5.0M$2.2M
2017-02-07D/A$12.0M$11.4M
2015-03-18D$5.0M$1.8M
2014-02-25D$2.0M$2.0M
2013-07-31D$6.0M$6.0M

More